VSTM logo

Verastem Inc

VSTM

$12.97

+ $0.83 (6.81%) This month

Closed: 1 Mar 2024 21:00 US/Eastern

Key details

CEO

Brian Stuglik

Employees

74

Headquarters

Needham, US

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About Verastem Inc

verastem, inc. (nasdaq: vstm) is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. cancer stem cells are an underlying cause of tumor recurrence and metastasis. verastem is translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer. for more information, please visit www.versatem.com

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG